Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0016020 | membrane | 2 | 2 |
Related structures:
AlphaFold database: E9AIS0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 128 | 132 | PF00656 | 0.314 |
CLV_NRD_NRD_1 | 140 | 142 | PF00675 | 0.432 |
CLV_NRD_NRD_1 | 97 | 99 | PF00675 | 0.509 |
CLV_PCSK_KEX2_1 | 140 | 142 | PF00082 | 0.432 |
CLV_PCSK_KEX2_1 | 145 | 147 | PF00082 | 0.458 |
CLV_PCSK_PC1ET2_1 | 145 | 147 | PF00082 | 0.316 |
CLV_PCSK_PC7_1 | 141 | 147 | PF00082 | 0.434 |
CLV_PCSK_SKI1_1 | 119 | 123 | PF00082 | 0.446 |
CLV_PCSK_SKI1_1 | 184 | 188 | PF00082 | 0.492 |
DOC_USP7_UBL2_3 | 192 | 196 | PF12436 | 0.346 |
LIG_14-3-3_CanoR_1 | 133 | 139 | PF00244 | 0.476 |
LIG_14-3-3_CanoR_1 | 4 | 8 | PF00244 | 0.481 |
LIG_BRCT_BRCA1_1 | 83 | 87 | PF00533 | 0.248 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.414 |
LIG_FHA_1 | 166 | 172 | PF00498 | 0.419 |
LIG_FHA_1 | 186 | 192 | PF00498 | 0.414 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.557 |
LIG_FHA_1 | 71 | 77 | PF00498 | 0.348 |
LIG_FHA_2 | 106 | 112 | PF00498 | 0.444 |
LIG_LIR_Gen_1 | 39 | 46 | PF02991 | 0.351 |
LIG_LIR_Gen_1 | 84 | 94 | PF02991 | 0.525 |
LIG_LIR_Nem_3 | 39 | 45 | PF02991 | 0.379 |
LIG_SH2_STAT5 | 169 | 172 | PF00017 | 0.413 |
LIG_SH2_STAT5 | 194 | 197 | PF00017 | 0.442 |
LIG_TRAF2_1 | 148 | 151 | PF00917 | 0.556 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.388 |
MOD_GlcNHglycan | 128 | 131 | PF01048 | 0.524 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.522 |
MOD_N-GLC_1 | 35 | 40 | PF02516 | 0.453 |
MOD_NEK2_1 | 105 | 110 | PF00069 | 0.367 |
MOD_NEK2_1 | 170 | 175 | PF00069 | 0.458 |
MOD_NEK2_1 | 37 | 42 | PF00069 | 0.517 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.334 |
MOD_NEK2_2 | 82 | 87 | PF00069 | 0.466 |
MOD_NMyristoyl | 1 | 7 | PF02799 | 0.469 |
MOD_PKA_2 | 3 | 9 | PF00069 | 0.494 |
MOD_Plk_4 | 134 | 140 | PF00069 | 0.450 |
MOD_Plk_4 | 165 | 171 | PF00069 | 0.504 |
MOD_Plk_4 | 190 | 196 | PF00069 | 0.268 |
MOD_Plk_4 | 37 | 43 | PF00069 | 0.519 |
MOD_Plk_4 | 76 | 82 | PF00069 | 0.429 |
MOD_SUMO_for_1 | 178 | 181 | PF00179 | 0.442 |
MOD_SUMO_rev_2 | 6 | 11 | PF00179 | 0.440 |
TRG_DiLeu_BaEn_1 | 151 | 156 | PF01217 | 0.488 |
TRG_ER_diArg_1 | 139 | 141 | PF00400 | 0.430 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I5J3 | Leptomonas seymouri | 72% | 100% |
A0A0S4IJA5 | Bodo saltans | 28% | 78% |
A0A1X0NST0 | Trypanosomatidae | 35% | 100% |
A0A3S7WZL3 | Leishmania donovani | 81% | 98% |
A0A422NVH2 | Trypanosoma rangeli | 40% | 100% |
A4I1W5 | Leishmania infantum | 80% | 98% |
C9ZS55 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 100% |
E9AY10 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 82% | 100% |
Q4Q9G3 | Leishmania major | 81% | 100% |
V5DR87 | Trypanosoma cruzi | 40% | 100% |